Mackenzie Financial Corp Buys 55,583 Shares of Maximus, Inc. (NYSE:MMS)

Mackenzie Financial Corp increased its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 2.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,782,150 shares of the health services provider's stock after buying an additional 55,583 shares during the period. Mackenzie Financial Corp owned 4.92% of Maximus worth $207,687,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its position in shares of Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after purchasing an additional 158 shares in the last quarter. V Square Quantitative Management LLC lifted its holdings in Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after buying an additional 180 shares in the last quarter. R Squared Ltd acquired a new stake in shares of Maximus in the 4th quarter valued at $54,000. IFP Advisors Inc increased its stake in shares of Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after buying an additional 302 shares during the period. Finally, Farther Finance Advisors LLC lifted its stake in shares of Maximus by 109.2% during the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after acquiring an additional 428 shares during the period. Institutional investors own 97.21% of the company's stock.

Maximus Trading Down 2.7%

Shares of MMS traded down $2.02 on Wednesday, reaching $72.68. 375,680 shares of the company's stock were exchanged, compared to its average volume of 561,086. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The stock has a market capitalization of $4.10 billion, a P/E ratio of 15.63 and a beta of 0.61. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The business has a 50 day moving average price of $69.59 and a two-hundred day moving average price of $71.93.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period last year, the company earned $1.57 EPS. The firm's revenue was up 1.0% on a year-over-year basis. Research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus's dividend payout ratio is currently 23.86%.

Insider Buying and Selling at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. The trade was a 11.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.60% of the company's stock.

Analysts Set New Price Targets

Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.